3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
161
Neoplasm Metastasis
27
Neoplasms
25
Breast Neoplasms, Male
15
Brain Neoplasms
14
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Stomach Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Ovarian Neoplasms
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Inflammatory Breast Neoplasms
5
Glioblastoma
5
Carcinoma, Non-Small-Cell Lung
5
Esophageal Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Unspecified Adult Solid Tumor, Protocol Specific
3
Salivary Gland Neoplasms
3
Recurrence
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Gliosarcoma
3
Glioma
3
Gallbladder Neoplasms
3
Ependymoma
3
Carcinoma, Squamous Cell
3
Triple Negative Breast Neoplasms
2
Solid Tumors
2
Osteitis Deformans
2
Interventions
Blood Specimen Collection
9
Liquid Biopsy
4
cabazitaxel
3
Trastuzumab
3
Surgical Procedures, Operative
3
Propofol
3
Bevacizumab
3
Standard of Care
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Morphine
2
Laparoscopy
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Cyclophosphamide
2
Cetuximab
2
Carboplatin
2
Aspirin
2
Anesthesia, General
2
ribociclib
1
pertuzumab
1
osimertinib
1
jinfukang
1
eribulin
1
Zoledronic Acid
1
Vinorelbine
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplastic Cells, Circulating
×
Lapatinib
×
Clear all
NCT01619111
2024-06-04
DETECT III
University of Ulm
Phase 3
Completed
105 enrolled